Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease

Journal of Nutritional Biochemistry

Volumn 20, Issue 9, 2009, Pages 657-662

  Spruss, Astrid ^a   Bergheim, Ina ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Endotoxin; Fructose; Intestinal barrier; NAFLD

Indexed keywords

CARBOHYDRATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FAT; FRUCTOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

BACTERIAL OVERGROWTH; CELL ACTIVATION; DIETARY INTAKE; DISEASE SEVERITY; FRUCTOSE METABOLISM; GENETIC TRANSCRIPTION; HUMAN; INTESTINE ABSORPTION; KUPFFER CELL; LIVER METABOLISM; MACRONUTRIENT; NONALCOHOLIC FATTY LIVER; NONHUMAN; OVERNUTRITION; PATHOGENESIS; PERMEABILITY BARRIER; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; DIETARY CARBOHYDRATES; DIETARY SUCROSE; FATTY LIVER; FRUCTOSE; GLUCOSE; HUMANS; INTESTINAL MUCOSA; LIVER; RISK FACTORS; TRANSCRIPTION, GENETIC;

EID: 68249086336     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.05.006     Document Type: Review

References (57)

1. Olufadi R., and Byrne C.D. Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol 61 (2008) 697-706
2. Xing J., and Chen J.D. Alterations of gastrointestinal motility in obesity. Obes Res 12 (2004) 1723-1732
3. Younossi Z.M. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 28 (2008) 2-12
4. Adams L.A., Lymp J.F., St S.J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129 (2005) 113-121
5. Gross L.S., Li L., Ford E.S., and Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 79 (2004) 774-779
6. Hanover L.M., and White J.S. Manufacturing, composition, and applications of fructose. Am J Clin Nutr 58 (1993) 724S-732S
7. US Department of Agriculture. The food pyramid (1992), US Dept of Agriculture
8. Forshee R.A., Storey M.L., Allison D.B., et al. A critical examination of the evidence relating high fructose corn syrup and weight gain. Crit Rev Food Sci Nutr 47 (2007) 561-582
9. Bray G.A., Nielsen S.J., and Popkin B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79 (2004) 537-543
10. Elliott S.S., Keim N.L., Stern J.S., Teff K., and Havel P.J. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76 (2002) 911-922
11. Vos M.B., Kimmons J.E., Gillespie C., Welsh J., and Blanck H.M. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med 10 (2008) 160
12. Park Y.K., and Yetley E.A. Intakes and food sources of fructose in the United States. Am J Clin Nutr 58 (1993) 737S-747S
13. Libuda L., Alexy U., Sichert-Hellert W., et al. Pattern of beverage consumption and long-term association with body-weight status in German adolescents-results from the DONALD study. Br J Nutr 99 (2008) 1370-1379
14. Thuy S., Ladurner R., Volynets V., et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 138 (2008) 1452-1455
15. Assy N., Nasser G., Kamayse I., et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 22 (2008) 811-816
16. Ouyang X., Cirillo P., Sautin Y., et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48 (2008) 993-999
17. Solga S., Alkhuraishe A.R., Clark J.M., et al. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci 49 (2004) 1578-1583
18. Bergheim I., Weber S., Vos M., et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48 (2008) 983-992
19. Zelber-Sagi S., Nitzan-Kaluski D., Goldsmith R., et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 47 (2007) 711-717
20. Castello A., Guma A., Sevilla L., et al. Regulation of GLUT5 gene expression in rat intestinal mucosa: regional distribution, circadian rhythm, perinatal development and effect of diabetes. Biochem J 309 Pt 1 (1995) 271-277
21. Havel P.J. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63 (2005) 133-157
22. Laville M., and Nazare J.A. Diabetes, insulin resistance and sugars. Obes Rev 10 Suppl 1 (2009) 24-33
23. Stanhope K.L., and Havel P.J. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 19 (2008) 16-24
24. Nagai Y., Nishio Y., Nakamura T., Maegawa H., Kikkawa R., and Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Am J Physiol Endocrinol Metab 282 (2002) E1180-E1190
25. Nagai Y., Yonemitsu S., Erion D.M., et al. The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab 9 (2009) 252-264
26. Lin J., Yang R., Tarr P.T., et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 120 (2005) 261-273
27. Takemoto T., Nishio Y., Sekine O., et al. RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet. FEBS Lett 581 (2007) 218-222
28. Yamashita H., Takenoshita M., Sakurai M., et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 98 (2001) 9116-9121
29. Rodriguez-Calvo R., Barroso E., Serrano L., et al. Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A. Hepatology 49 (2009) 106-115
30. Purohit V., Bode J.C., Bode C., et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 42 (2008) 349-361
31. Drenick E.J., Fisler J., and Johnson D. Hepatic steatosis after intestinal bypass-prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology 82 (1982) 535-548
32. Kim W.R., Poterucha J.J., Porayko M.K., Dickson E.R., Steers J.L., and Wiesner R.H. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation 62 (1996) 1802-1805
33. Bode C., Kugler V., and Bode J.C. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 4 (1987) 8-14
34. Soza A., Riquelme A., Gonzalez R., et al. Increased orocecal transit time in patients with nonalcoholic fatty liver disease. Dig Dis Sci 50 (2005) 1136-1140
35. Wigg A.J., Roberts-Thomson I.C., Dymock R.B., McCarthy P.J., Grose R.H., and Cummins A.G. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48 (2001) 206-211
36. Farhadi A., Gundlapalli S., Shaikh M., et al. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int 28 (2008) 1026-1033
37. Ruiz A.G., Casafont F., Crespo J., et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 17 (2007) 1374-1380
38. Rivera C.A., Adegboyega P., van R.N., Tagalicud A., Allman M., and Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 47 (2007) 571-579
39. Brun P., Castagliuolo I., Di V L., et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292 (2007) G518-G525
40. Logan B.K., and Jones A.W. Endogenous ethanol 'auto-brewery syndrome' as a drunk-driving defence challenge. Med Sci Law 40 (2000) 206-215
41. McManus I.R., Contag A.O., and Olson R.E. Characterization of endogenous ethanol in the mammal. Science 131 (1960) 102-103
42. Baraona E., Julkunen R., Tannenbaum L., and Lieber C.S. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 90 (1986) 103-110
43. Mezey E., Imbembo A.L., Potter J.J., Rent K.C., Lombardo R., and Holt P.R. Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity. Am J Clin Nutr 28 (1975) 1277-1283
44. Hunnisett A., Howard J., and Davies S. Gut fermentation (or auto-brewery) syndrome. A new clinical test with initial observations and discussion of clinical and biological implications. J Nutr Med 1 (1990) 33-38
45. Cope K., Risby T., and Diehl A.M. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119 (2000) 1340-1347
46. Nair S., Cope K., Risby T.H., and Diehl A.M. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 96 (2001) 1200-1204
47. Armutcu F., Coskun O., Gurel A., et al. Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin Biochem 38 (2005) 540-547
48. Busserolles J., Gueux E., Rock E., Mazur A., and Rayssiguier Y. Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J Nutr 132 (2002) 3379-3382
49. Busserolles J., Gueux E., Rock E., Demigne C., Mazur A., and Rayssiguier Y. Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J Nutr 133 (2003) 1903-1908
50. McDonald R.B. Influence of dietary sucrose on biological aging. Am J Clin Nutr 62 (1995) 284S-292S
51. Suganthi R., Rajamani S., Ravichandran M.K., and Anuradha C.V. Effect of food seasoning spices mixture on biomarkers of oxidative stress in tissues of fructose-fed insulin-resistant rats. J Med Food 10 (2007) 149-153
52. Farrell G.C., Teoh N.C., and McCuskey R.S. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken ) 291 (2008) 684-692
53. Ackerman Z., Oron-Herman M., Rosenthal T., et al. Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver. Dig Dis Sci 53 (2008) 777-784
54. Cavarape A., Feletto F., Mercuri F., Quagliaro L., Daman G., and Ceriello A. High-fructose diet decreases catalase mRNA levels in rat tissues. J Endocrinol Invest 24 (2001) 838-845
55. Yadav H., Jain S., Prasad G.B., and Yadav M. Preventive effect of diabegon, a polyherbal preparation, during progression of diabetes induced by high-fructose feeding in rats. J Pharmacol Sci 105 (2007) 12-21
56. Bode C., and Bode J.C. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?. Alcohol Clin Exp Res 29 (2005) 166S-171S
57. Bergheim I., Guo L., Davis M.A., et al. Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1. Gastroenterology 130 (2006) 2099-2112